Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chang-Ching Lin

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The American Journal of Chinese Medicine|February 3, 2012
Herb-drug interaction of 50 Chinese herbal medicines on CYP3A4 activity in vitro and in vivoLi-Heng Pao, Oliver Yoa-Pu Hu, Hsien-Yuan Fan, et al.
Carbohydrate Research|June 10, 2006
Multi-enzyme one-pot strategy for the synthesis of sialyl Lewis X-containing PSGL-1 glycopeptideKuo-Ting Huang, Bing-Ching Wu, Chang-Ching Lin, et al.
The Journal of Organic Chemistry|June 29, 2010
5-N,4-O-carbonyl-7,8,9-tri-O-chloroacetyl-protected sialyl donor for the stereoselective synthesis of alpha-(2-->9)-tetrasialic acidChang-Ching Lin, Nai-Pin Lin, L Sk Sahabuddin, et al.
Bioorganic & Medicinal Chemistry|May 26, 2004
Versatile approach for the synthesis of novel seven-membered iminocyclitols via ring-closing metathesis dihydroxylation reactionChang-Ching Lin, Yi-Shin Pan, Laxmikant N Patkar, et al.
Cancer Letters|April 2, 2020
Corrigendum to "Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer" [Canc. Lett. 438 (2018, Dec 1) 165-173]Chang-Ching Lin, Miao-Chia Lo, Rebecca Moody, et al.
Cancer Letters|September 19, 2018
Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancerChang-Ching Lin, Miao-Chia Lo, Rebecca Moody, et al.
The Journal of Biological Chemistry|December 22, 2017
Probing the interaction between the histone methyltransferase/deacetylase subunit RBBP4/7 and the transcription factor BCL11A in epigenetic complexesRebecca Reed Moody, Miao-Chia Lo, Jennifer L Meagher, et al.
Oncotarget|June 11, 2016
Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancerLichao Sun, Joseph Burnett, Mari Gasparyan, et al.
Cancer Letters|July 6, 2025
Corrigendum to "Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer" [604 (2024) 217219 1-12]María Rosario Chica-Parrado, Gun Min Kim, Yasuaki Uemoto, et al.
Cancer Letters|September 7, 2024
Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancerMaría Rosario Chica-Parrado, Gun Min Kim, Yasuaki Uemoto, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The American Journal of Chinese Medicine|February 3, 2012
Herb-drug interaction of 50 Chinese herbal medicines on CYP3A4 activity in vitro and in vivoLi-Heng Pao, Oliver Yoa-Pu Hu, Hsien-Yuan Fan, et al.
Carbohydrate Research|June 10, 2006
Multi-enzyme one-pot strategy for the synthesis of sialyl Lewis X-containing PSGL-1 glycopeptideKuo-Ting Huang, Bing-Ching Wu, Chang-Ching Lin, et al.
The Journal of Organic Chemistry|June 29, 2010
5-N,4-O-carbonyl-7,8,9-tri-O-chloroacetyl-protected sialyl donor for the stereoselective synthesis of alpha-(2-->9)-tetrasialic acidChang-Ching Lin, Nai-Pin Lin, L Sk Sahabuddin, et al.
Bioorganic & Medicinal Chemistry|May 26, 2004
Versatile approach for the synthesis of novel seven-membered iminocyclitols via ring-closing metathesis dihydroxylation reactionChang-Ching Lin, Yi-Shin Pan, Laxmikant N Patkar, et al.
Cancer Letters|April 2, 2020
Corrigendum to "Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer" [Canc. Lett. 438 (2018, Dec 1) 165-173]Chang-Ching Lin, Miao-Chia Lo, Rebecca Moody, et al.
Cancer Letters|September 19, 2018
Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancerChang-Ching Lin, Miao-Chia Lo, Rebecca Moody, et al.
The Journal of Biological Chemistry|December 22, 2017
Probing the interaction between the histone methyltransferase/deacetylase subunit RBBP4/7 and the transcription factor BCL11A in epigenetic complexesRebecca Reed Moody, Miao-Chia Lo, Jennifer L Meagher, et al.
Oncotarget|June 11, 2016
Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancerLichao Sun, Joseph Burnett, Mari Gasparyan, et al.
Cancer Letters|July 6, 2025
Corrigendum to "Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer" [604 (2024) 217219 1-12]María Rosario Chica-Parrado, Gun Min Kim, Yasuaki Uemoto, et al.
Cancer Letters|September 7, 2024
Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancerMaría Rosario Chica-Parrado, Gun Min Kim, Yasuaki Uemoto, et al.
Pageof 4